Skip to main content
See every side of every news story
Published loading...Updated

Amgen, Lilly can continue fight over alleged improper drug discounts, judge rules

Summary by endpoints.news
Amgen, Eli Lilly and UCB can proceed with a lawsuit that claims HHS improperly certified a string of clinics to receive discounts through the federal 340B program. DC Federal Judge James Boasberg on Monday ...
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

endpoints.news broke the news in on Tuesday, August 5, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal